KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$57.13
+2.02 (+3.67%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+36.02%
1Y
+98.92%
YTD
+36.01%
Open$55.69
Previous Close$55.11
Day High$57.81
Day Low$55.69
52W High$59.87
52W Low$26.27
Volume—
Avg Volume518.7K
Market Cap4.24B
P/E Ratio58.04
EPS$0.91
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.51
Above
SMA 200
$35.71
Above
RSI (14)
68.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+27.2% upside
Current
$57.13
$57.13
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 660.05M | 453.80M | 434.64M |
| Net Income | 57.48M | 35.57M | -80,259,876 |
| Profit Margin | 8.7% | 8.3% | -18.5% |
| EBITDA | 76.74M | 50.12M | -90,838,119 |
| Free Cash Flow | — | — | -118,111,706 |
| Rev Growth | +45.5% | +45.5% | +6.7% |
| Debt/Equity | — | — | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $233.69 | +1.60% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.34 | +0.76% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.84 | +0.78% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $469.49 | +0.58% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.15 | +0.92% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $287.84 | +0.50% | 64.3 | 37.13B |